Literature DB >> 12489503

The role of hepcidin in iron sequestration during infections and in the pathogenesis of anemia of chronic disease.

Tomas Ganz1.   

Abstract

Systemic infection or inflammation causes a decrease in intestinal iron absorption and impairs the release of recycled iron from macrophages. Decreased availability of iron may deny this essential element to invading pathogens and may inhibit their multiplication and other metabolic processes but also results in anemia of chronic disease. This article reviews recent discoveries that shed light on the regulation of iron metabolism during infection and iron overload, and point to the central role of a newly discovered peptide, hepcidin. Evidence to date indicates that hepcidin is a negative regulator of intestinal iron absorption, placental iron transport, and the release of iron from macrophages that recycle iron from senescent red cells. It may also be the central mediator of iron sequestration during infections and inflammatory states and the mediator of anemia of chronic disease. Rapid progress in this area is a good example of the beneficial effects of improvements in peptide analysis and chemistry, advances in genomics, and the increasing use of transgenic mice to determine the function of newly discovered genes and proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12489503

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  23 in total

Review 1.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

Review 2.  Antimicrobial anxiety: the impact of stress on antimicrobial immunity.

Authors:  Katherine A Radek
Journal:  J Leukoc Biol       Date:  2010-05-04       Impact factor: 4.962

Review 3.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

4.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

5.  Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3).

Authors:  Gunda Millonig; Ingo Ganzleben; Teresa Peccerella; Guillem Casanovas; Lidia Brodziak-Jarosz; Katja Breitkopf-Heinlein; Tobias P Dick; Helmut-Karl Seitz; Martina U Muckenthaler; Sebastian Mueller
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

6.  Molecular cloning and characterization of three beta-defensins from canine testes.

Authors:  Yongming Sang; M Teresa Ortega; Frank Blecha; Om Prakash; Tonatiuh Melgarejo
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria.

Authors:  Florence Burté; Biobele J Brown; Adebola E Orimadegun; Wasiu A Ajetunmobi; Nathaniel K Afolabi; Francis Akinkunmi; Olayinka Kowobari; Samuel Omokhodion; Kikelomo Osinusi; Felix O Akinbami; Wuraola A Shokunbi; Olugbemiro Sodeinde; Delmiro Fernandez-Reyes
Journal:  Blood       Date:  2013-02-04       Impact factor: 22.113

Review 8.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

Review 9.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

10.  Characterization and structural analysis of hepcidin like antimicrobial peptide from Schizothorax richardsonii (Gray).

Authors:  Preeti Chaturvedi; Meenakshi Dhanik; Amit Pande
Journal:  Protein J       Date:  2014-02       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.